BIOMEDICAL POTENTIAL OF THE SPORE-RECOMBINANT STRAIN <i>BACILLUS SUBTILIS</i> 2335/105 IN THE COMPOSITION OF SUBALIN®, AS A LIVING THERAPEUTIC SYSTEM FOR THE DELIVERY OF ALPHA-INTERFERON IN VIRAL LEUKEMIA: ASSESSMENT OF THE EFFECT ON IMMUNE CELLS AND ORGANS OF MICE IN THE EXPERIMENT OF VIRAL LEUKEMIA
Author(s) -
Ya. L. Rusakova,
О. В. Казаков,
V. A. Belyavskaya
Publication year - 2020
Publication title -
innovations and food safety
Language(s) - English
Resource type - Journals
ISSN - 2311-0651
DOI - 10.31677/2311-0651-2019-24-2-85-93
Subject(s) - immune system , spleen , recombinant dna , medicine , immunity , drug delivery , pharmacology , lymph , immunology , bacillus subtilis , microbiology and biotechnology , chemistry , biology , pathology , biochemistry , bacteria , organic chemistry , gene , genetics
To maintain a healthy immune system in animals, especially under conditions unfavorable for viral leukemia, a promising delivery system of biologically active molecules is considered – Subalin, a live delivery system. As a result of research, it has been established that with intraperitoneal and intravenous administration to animals, Subalin is harmless to animals, even at doses many times higher than the therapeutic one. With the introduction of the drug Subalin in animals stimulated humoral and cellular immunity, as evidenced by morphofunctional reorganization of the lymphoid system (spleen, lymph nodes). With the simultaneous administration of Subaline with a virus-containing suspension, subtility therapy had a stabilizing effect on the macroorganism, restraining the development of viral carcinogenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom